These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11281956)

  • 1. Dopamine receptor D3 gene and response to lithium prophylaxis in mood disorders.
    Serretti A; Lilli R; Lorenzi C; Franchini L; Smeraldi E
    Int J Neuropsychopharmacol; 1998 Dec; 1(2):125-129. PubMed ID: 11281956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tryptophan hydroxylase gene and response to lithium prophylaxis in mood disorders.
    Serretti A; Lilli R; Lorenzi C; Gasperini M; Smeraldi E
    J Psychiatr Res; 1999; 33(5):371-7. PubMed ID: 10504005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine receptor D2 and D4 genes, GABA(A) alpha-1 subunit genes and response to lithium prophylaxis in mood disorders.
    Serretti A; Lilli R; Lorenzi C; Franchini L; Di Bella D; Catalano M; Smeraldi E
    Psychiatry Res; 1999 Jul; 87(1):7-19. PubMed ID: 10512150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin transporter gene associated with lithium prophylaxis in mood disorders.
    Serretti A; Lilli R; Mandelli L; Lorenzi C; Smeraldi E
    Pharmacogenomics J; 2001; 1(1):71-7. PubMed ID: 11913731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics of lithium prophylaxis in mood disorders: analysis of COMT, MAO-A, and Gbeta3 variants.
    Serretti A; Lorenzi C; Lilli R; Mandelli L; Pirovano A; Smeraldi E
    Am J Med Genet; 2002 May; 114(4):370-9. PubMed ID: 11992559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin receptor 2A, 2C, 1A genes and response to lithium prophylaxis in mood disorders.
    Serretti A; Lorenzi C; Lilli R; Smeraldi E
    J Psychiatr Res; 2000; 34(2):89-98. PubMed ID: 10758249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disorders.
    Serretti A; Malitas PN; Mandelli L; Lorenzi C; Ploia C; Alevizos B; Nikolaou C; Boufidou F; Christodoulou GN; Smeraldi E
    Pharmacogenomics J; 2004; 4(4):267-73. PubMed ID: 15111989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine receptor D2 and D3 gene variants are not associated with the antidepressant effect of total sleep deprivation in bipolar depression.
    Benedetti F; Serretti A; Colombo C; Lilli R; Lorenzi C; Smeraldi E
    Psychiatry Res; 2003 Jun; 118(3):241-7. PubMed ID: 12834818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine D3 receptor gene not associated with symptomatology of major psychoses.
    Serretti A; Lattuada E; Cusin C; Lilli R; Lorenzi C; Smeraldi E
    Am J Med Genet; 1999 Oct; 88(5):476-80. PubMed ID: 10490702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up.
    Baethge C; Gruschka P; Berghöfer A; Bauer M; Müller-Oerlinghausen B; Bschor T; Smolka MN
    J Affect Disord; 2004 Apr; 79(1-3):43-50. PubMed ID: 15023479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pathogenic aspects of candidate genes for lithium prophylactic efficacy.
    Rybakowski JK; Czerski P; Dmitrzak-Weglarz M; Kliwicki S; Leszczynska-Rodziewicz A; Permoda-Osip A; Skibinska M; Suwalska A; Szczepankiewicz A; Hauser J
    J Psychopharmacol; 2012 Mar; 26(3):368-73. PubMed ID: 21890592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classifying mood disorders by age-at-onset instead of polarity.
    Benazzi F
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):86-93. PubMed ID: 18992784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased levels of dopamine D3 receptor mRNA in schizophrenic and bipolar patients.
    Vogel M; Pfeifer S; Schaub RT; Grabe HJ; Barnow S; Freyberger HJ; Cascorbi I
    Neuropsychobiology; 2004; 50(4):305-10. PubMed ID: 15539862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism of circadian clock genes and prophylactic lithium response.
    Rybakowski JK; Dmitrzak-Weglar M; Kliwicki S; Hauser J
    Bipolar Disord; 2014 Mar; 16(2):151-8. PubMed ID: 24636202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the dopamine D3 receptor (DRD3) gene polymorphisms on risperidone response: a pharmacogenetic study.
    Xuan J; Zhao X; He G; Yu L; Wang L; Tang W; Li X; Gu N; Feng G; Xing Q; He L
    Neuropsychopharmacology; 2008 Jan; 33(2):305-11. PubMed ID: 17429404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the DRD3 and BDNF gene variants in subtyped bipolar disorder.
    Lee SY; Chen SL; Chen SH; Chu CH; Chang YH; Lin SH; Huang SY; Tzeng NS; Kuo PH; Lee IH; Yeh TL; Yang YK; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):382-7. PubMed ID: 22877924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene.
    Rybakowski JK; Suwalska A; Skibinska M; Szczepankiewicz A; Leszczynska-Rodziewicz A; Permoda A; Czerski PM; Hauser J
    Pharmacopsychiatry; 2005 Jul; 38(4):166-70. PubMed ID: 16025419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium in the long-term treatment of bipolar disorders.
    Kleindienst N; Greil W
    Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):120-5. PubMed ID: 12904975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catechol-O-methyltransferase gene variants in mood disorders in the Italian population.
    Serretti A; Rotondo A; Lorenzi C; Smeraldi E; Cassano GB
    Psychiatr Genet; 2006 Oct; 16(5):181-2. PubMed ID: 16969269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.